Home > Boards > US Listed > Biotechs >

Crucell (CRXL)

Add CRXL Price Alert      Hide Sticky   Hide Intro
Search This Board: 
Last Post: 9/27/2010 1:59:11 PM - Followers: 3 - Board type: Free - Posts Today: 0 Crucell N.V., an integrated biopharmaceutical company, focuses on the development, production, and marketing of vaccines and antibodies to prevent or treat infectious diseases. Its paediatric product portfolio comprises Quinvaxem, a liquid vaccine for five childhood diseases; Epaxal Junior, a hepatitis A vaccine; Hepavax-Gene, a vaccine against hepatitis B; and MoRu-Viraten, a vaccine for protection against measles and rubella. The company also markets various travel and endemic vaccines, such as Epaxal, an aluminum-free hepatitis A vaccine; Vivotif, the oral anti-typhoid vaccine; and Dukoral, an oral cholera vaccine. Its respiratory products include Inflexal, a virosome-adjuvanted vaccine for influenza. In addition, Crucell N.V. licenses various proprietary technologies, such as the PER.C6, a human designer cell line for the development and manufacturing of biopharma products; AdVac, which is used in combination with PER.C6 to develop recombinant vaccines; MAbstract for the discovery of drug targets and identification of human antibodies; STAR that is designed for the production yields of recombinant human antibodies and proteins on mammalian cell lines; Virosome, a vehicle enabling the use of virus antigens in the making of vaccinations; and Hansenula polymorpha expression system technology, which is used as a basis for developing and manufacturing new vaccines. Further, the company's products under development include vaccines against yellow fever, influenza, ebola, HIV, malaria, tuberculosis, human monoclonal antibodies against rabies, H5N1 antibodies, and pandemic influenza virus, as well as blood coagulation factors. Crucell N.V. markets its products through own sales force and distribution partners in Europe, North America, and Asia. Its strategic partners comprise DSM Biologics, Novartis, MedImmune, Merck, sanofi Pasteur, and Wyeth. The company was founded in 1993 and is based in Leiden, the Netherlands.
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#41   Congrats Surf mkinhaw 09/17/10 02:07:21 PM
#40   Dropping CRXL MOD position, another biotech buyout in surf1944 09/17/10 09:17:35 AM
#39   1:52AM Crucell N.V. and Johnson & Johnson in surf1944 09/17/10 08:45:18 AM
#38   6:43AM Crucell N.V. join forces with IAVI to surf1944 08/11/10 08:00:47 AM
#37   2:02AM Crucell N.V. reaches agreement with sanofi pasteur surf1944 07/08/10 09:22:44 AM
#36   1:52AM On The Wires : Crucell N.V. (CRXL) surf1944 05/11/10 08:37:47 AM
#33   Our Top Biotech Takeout Picks for 2010 surf1944 05/10/10 08:30:06 AM
#32   Crucell N.V. CRXL UBS Neutral » Buy surf1944 04/19/10 09:47:26 AM
#31   2:39AM Crucell N.V. announces collaboration with GlaxoSmithKline Biologicals surf1944 04/06/10 09:53:35 AM
#30 surf1944 03/13/10 10:52:59 AM
#28   Crucell N.V. CRXL downgraded today by UBS from surf1944 02/10/10 10:15:04 AM
#27   2:32AM Crucell announces FY09 results (CRXL) 19.19 : surf1944 02/09/10 08:35:31 AM
#26   Crucell N.V. CRXL Jefferies & Co downgraded from surf1944 01/12/10 09:23:26 AM
#25   Johnson & Johnson buys 18 percent stake in Crucell surf1944 09/28/09 09:55:51 AM
#23   The CRXL market makers & traders didn't hide surf1944 01/07/09 04:11:39 PM
#22   wow, what a run ............ bagfull 01/07/09 04:07:20 PM
#21   Wyeth in Talks to buy CRXL Legato 01/07/09 03:46:07 PM
#20   Crucell's 2Q loss narrows on higher vaccine sales surf1944 08/23/08 11:17:56 AM
#19   Crucell Announces Second Quarter 2008 Results surf1944 08/23/08 11:17:10 AM
#18   DSM and Crucell Sign Agreement with Avid Bioservices surf1944 07/14/08 12:02:57 PM
#17   Crucell Announces First Quarter 2008 Results surf1944 05/13/08 09:20:20 AM
#16   Aeras, Crucell and South African Tuberculosis Vaccine Initiative surf1944 04/09/08 09:19:19 AM
#15   Crucell Announces First in Man Study with New surf1944 04/03/08 10:02:25 AM
#14   Crucell Announces Start of Phase II Clinical Study surf1944 04/03/08 10:01:51 AM
#13   Wake up brother : ) Paul A 01/24/07 02:43:01 PM
#12   Good weekend sitting duck! geesh, the yahoo Paul A 12/02/06 10:11:14 AM
#11   Crucell Announces Acquisition of SBL Vaccin AB and SittingDuck 11/22/06 01:49:29 PM
#10 Paul A 11/14/06 09:27:49 AM
#9   A post from the yahoo finance board (credit SittingDuck 10/09/06 04:54:49 PM
#8   Check analyst oppinions on Yahoo finance: SittingDuck 10/09/06 04:49:43 PM
#7   Yahoo finance SittingDuck 10/09/06 04:48:59 PM
#6   Call for intelligence ;-) Anyone who SittingDuck 10/09/06 04:14:19 PM
#5   For those who don't know yet... There was SittingDuck 10/09/06 04:06:24 PM
#4   List Buy & Sell recommendations for CRUCELL: SittingDuck 10/09/06 04:01:11 PM
#3   $16.2 million NIH Contract for HIV Vaccine Design SittingDuck 10/09/06 03:52:52 PM
#2   Hello!! Sorry but I has been busy lately ;-) SittingDuck 10/09/06 03:46:51 PM
#1   Hello SD : ) Paul A 09/24/06 03:34:38 PM